{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "SARS-CoV-2",
      "Vaccines"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33230278",
  "DateCompleted": {
    "Year": "2020",
    "Month": "12",
    "Day": "07"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "12",
    "Day": "14"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/d41586-020-03326-w"
    ],
    "Journal": {
      "ISSN": "1476-4687",
      "JournalIssue": {
        "Volume": "588",
        "Issue": "7836",
        "PubDate": {
          "Year": "2020",
          "Month": "Dec"
        }
      },
      "Title": "Nature",
      "ISOAbbreviation": "Nature"
    },
    "ArticleTitle": "Why Oxford's positive COVID vaccine results are puzzling scientists.",
    "Pagination": {
      "StartPage": "16",
      "EndPage": "18",
      "MedlinePgn": "16-18"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Callaway",
        "ForeName": "Ewen",
        "Initials": "E"
      }
    ],
    "PublicationTypeList": [
      "News"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Nature",
    "NlmUniqueID": "0410462",
    "ISSNLinking": "0028-0836"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "immunology",
        "prevention & control",
        "transmission"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "immunology",
        "supply & distribution"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Clinical Trials, Phase III as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Industry"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunization Schedule"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Models, Immunological"
    },
    {
      "QualifierName": [
        "chemistry",
        "immunology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "United Kingdom"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Vaccination"
    }
  ]
}